Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Upadacitinib effectively treats pyoderma gangrenosum.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

A special gel with medicine helps prevent melanoma from coming back after surgery.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Rhabdomyosarcoma is the most common head and neck cancer in children, requiring complex treatment.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Intralesional pentoxifylline effectively and safely treats alopecia areata, improving hair regrowth.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

Compound 1 showed promising anticancer activity.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Zinc oxide nanoparticles made from Tridax procumbens leaves show strong antibacterial and anticancer effects.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Iontophoresis improves minoxidil delivery for alopecia treatment.